Showing results (971-980 of 1,241) with videos related to
Sort By:
Pageof 125
ESC Heart Failure|December 10, 2020
Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysisMarat Fudim, Nicolas Ashur, Aaron D Jones, et al.Diabetes Care|April 24, 2019
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)M Angelyn Bethel, Rishi A Patel, Vivian P Thompson, et al.Journal of Cardiac Failure|April 23, 2022
Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart FailureAdrian F Hernandez, Nancy M Albert, Larry A Allen, et al.The New England Journal of Medicine|August 26, 2023
Ferric Carboxymaltose in Heart Failure with Iron DeficiencyRobert J Mentz, Jyotsna Garg, Frank W Rockhold, et al.American Heart Journal|January 19, 2024
Drug development for major chronic health conditions-aligning with growing public health needs: Proceedings from a multistakeholder think tankKonstantin A Krychtiuk, Tomas Lg Andersson, Ulrike Bodesheim, et al.Diabetologia|June 14, 2019
Correction to: In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD miceMidhat H Abdulreda, R Damaris Molano, Gaetano Faleo, et al.JAMA Neurology|July 23, 2019
Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) StudyYing Xian, Haolin Xu, Emily C O'Brien, et al.Lancet (London, England)|August 30, 2022
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trialsMuthiah Vaduganathan, Kieran F Docherty, Brian L Claggett, et al.JACC. Heart Failure|May 3, 2023
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIAJaved Butler, Yinggan Zheng, Muhammad Shahzeb Khan, et al.Journal of Cardiac Failure|May 27, 2024
Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF TrialMarat Fudim, Derek D Cyr, Jonathan H Ward, et al.Pageof 125